RecruitingPhase 3Drug trialEfficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsThe purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine.